Backpedalling on EMA’s “proactive publication of clinical-data” draft policy: Was it all just a window-dressing exercise? Who or what is the EMA afraid of?
Attachment: 20140520_ematransparencypolicy.pdf
The November 2014 issue of the ISDB Newsletter (vol 29, issue 2) includes:
The European Medicines Agency (EMA) draft policy on “publication and access to clinical-trial data” could pave the way to a new era in the disclosure of clinical data on medicines.
Download NewsLetter ISDB (650 KB)